• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

Cumberland Pharmaceuticals

by FSA Webmaster

Booth #113

2525 West End Avenue, Suite 950
Nashville, TN  37203
Telephone: 615-255-0068
Fax: 615-255-0094
Website: www.cumberlandpharma.com

Caldolor® (ibuprofen) Injection is indicated in adults for the management of mild to moderate pain, the management of moderate to severe pain as an adjunct to opioid analgesics, and for the reduction of fever.  Caldolor can be administered pre-, intra- and post-operatively.  Caldolor is marketed by Cumberland Pharmaceuticals, Inc.

Category: 2014 Exhibits, 2015 ExhibitsTag: Cumberland Pharmaceuticals

About FSA Webmaster

Previous Post:Cook Medical
Next Post:The Doctor’s Company

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved